154 related articles for article (PubMed ID: 31289540)
21. Antitumor effect of miR-27b-3p on lung cancer cells via targeting Fzd7.
Sun Y; Xu T; Cao YW; Ding XQ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4113-4123. PubMed ID: 29028088
[TBL] [Abstract][Full Text] [Related]
22. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
[TBL] [Abstract][Full Text] [Related]
23. Differential effect of cancer-associated fibroblast-derived extracellular vesicles on cisplatin resistance in oral squamous cell carcinoma
Kang SH; Oh SY; Lee KY; Lee HJ; Kim MS; Kwon TG; Kim JW; Lee ST; Choi SY; Hong SH
Theranostics; 2024; 14(2):460-479. PubMed ID: 38169528
[No Abstract] [Full Text] [Related]
24. [Effect of circular RNA hsa_circ_0008898 on oral squamous cell carcinoma and its mechanism].
Zhou HX; Wang LY; Chen S; Wang DD; Fang Z
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):578-585. PubMed ID: 32842350
[No Abstract] [Full Text] [Related]
25. ZFAS1 Promotes Cisplatin Resistance via Suppressing miR-421 Expression in Oral Squamous Cell Carcinoma.
Wang X; Hao R; Wang F; Wang F
Cancer Manag Res; 2020; 12():7251-7262. PubMed ID: 32884341
[TBL] [Abstract][Full Text] [Related]
26. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
Chen ZF; Wang Y; Sun LL; Ding SY; Jinag H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5436-5445. PubMed ID: 32495922
[TBL] [Abstract][Full Text] [Related]
27. Expression and effect of miR‑27b in primary liver cancer.
Zhuo L; Zhan L; Chen H; Zhang W; Huang A
Oncol Lett; 2024 Feb; 27(2):65. PubMed ID: 38192658
[TBL] [Abstract][Full Text] [Related]
28. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
[TBL] [Abstract][Full Text] [Related]
29. MiR-92a inhibits proliferation and promotes apoptosis of OSCC cells through Wnt/β-catenin signaling pathway.
Zheng TL; Cen K
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4803-4809. PubMed ID: 32432743
[TBL] [Abstract][Full Text] [Related]
30. Role of miR-218-GREM1 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma: An in vivo and vitro study based on microarray data.
Wang Y; Jiang Y; Chen L
J Cell Mol Med; 2020 Dec; 24(23):13824-13836. PubMed ID: 33107676
[TBL] [Abstract][Full Text] [Related]
31. GAS5 alleviates cisplatin drug resistance in oral squamous cell carcinoma by sponging miR-196a.
Yuan X; Jing Y; Guang M; Zhu J; Wang J; Wang Y; Zhang Y
J Int Med Res; 2022 Oct; 50(10):3000605221132456. PubMed ID: 36310502
[TBL] [Abstract][Full Text] [Related]
32. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
Cui SH; Hu XD; Yan Y
J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
[TBL] [Abstract][Full Text] [Related]
33. The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.
Fukumoto I; Koshizuka K; Hanazawa T; Kikkawa N; Matsushita R; Kurozumi A; Kato M; Okato A; Okamoto Y; Seki N
Int J Oncol; 2016 Sep; 49(3):1119-29. PubMed ID: 27573718
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-27b-3p inhibits the proliferation and invasion of cutaneous squamous cell carcinoma by targeting EGFR and MMP-13.
Liang D; Zhang Z
Oncol Lett; 2021 Oct; 22(4):729. PubMed ID: 34429769
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-134 inhibits tumor stem cell migration and invasion in oral squamous cell carcinomas via downregulation of PI3K-Akt signaling pathway by inhibiting LAMC2 expression.
Zhou YM; Yao YL; Liu W; Shen XM; Shi LJ; Wu L
Cancer Biomark; 2020; 29(1):51-67. PubMed ID: 32568182
[TBL] [Abstract][Full Text] [Related]
36. MEHP promotes the proliferation of oral cancer cells via down regulation of miR-27b-5p and miR-372-5p.
Wang M; Qiu Y; Zhang R; Gao L; Wang X; Bi L; Wang Y
Toxicol In Vitro; 2019 Aug; 58():35-41. PubMed ID: 30858031
[TBL] [Abstract][Full Text] [Related]
37. Investigating the role and mechanism of microRNA-196a in oral squamous cell carcinoma by targeting FOXO1.
Song H; Lai L; Liu M; Wang X; Zhang J; Zhang S
Exp Ther Med; 2020 Jun; 19(6):3707-3715. PubMed ID: 32346435
[TBL] [Abstract][Full Text] [Related]
38. Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells.
Sun L; Wang K; Peng L; Zhang J; Yang J; Zhao J; Xu J; Zheng J; Zeng Y
Cancer Manag Res; 2021; 13():1843-1851. PubMed ID: 33658848
[TBL] [Abstract][Full Text] [Related]
39. The role and mechanism of circ-BNC2 on the malignant progression of oral squamous cell carcinoma.
Xia Y; Hei N; Peng S; Cui Z
Head Neck; 2023 Sep; 45(9):2424-2437. PubMed ID: 37377048
[TBL] [Abstract][Full Text] [Related]
40. Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma.
Song A; Wu Y; Chu W; Yang X; Zhu Z; Yan E; Zhang W; Zhou J; Ding X; Liu J; Zhu H; Ye J; Wu Y; Zheng Y; Song X
Int J Biol Sci; 2021; 17(2):430-447. PubMed ID: 33613103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
